A new $10.4m vehicle targeting South Africa's university ecosystem is due to be approved on September 28.

The Visegrad Fund has been pumping money into driving innovation and entrepreneurship across Czech Republic, Hungary, Poland and Slovakia.

University of California-aligned Mission Bay Capital's third fund attracted UC Investments, Eli Lilly, Astellas Pharma and Wilson Sonsini Goodrich & Rosati as limited partners.

Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.

Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Laser project technology company Casiris Technology lured Cash Capital and Cas Star to the table for its series D-plus round.

Woodford Investment Management is reportedly poised for another beating as its portfolio company BenevolentAI seeks funding from Temasek at half of its previous $2bn valuation.

Max Planck Foundation joined the EIF and AWS as a limited partner in university-focused drug discovery fund Khan Technology Transfer Fund I.

Osage University Partners has celebrated an exit as migraine treatment developer Satsuma Pharmaceuticals listed on the Nasdaq Global Market following an $82.5m offering.